| Financial Year |
March 31 2022 |
| Monetary Funds |
191,336,262.06 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,659,698,217.66 |
| Advances to Suppliers |
630,537,176.86 |
| Other Receivables |
190,135,402.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
185,909,991.48 |
| Total Current Assets |
2,861,417,050.74 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,204,624.80 |
| Long-term Equity Investment |
2,232,879,952.42 |
| Investment Properties |
-- |
| Fixed Assetes |
5,263,022,604.64 |
| Under-construction Projects |
1,506,840,156.49 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
81,544,850.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,730,861.76 |
| Deferred Income Tax Assets |
24,658,414.47 |
| Other Non-Current Assets |
320,141,043.21 |
| Sub-Total of Non-Current Assets |
9,450,745,015.33 |
| Total Assets |
12,312,162,066.07 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
646,615,287.69 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,159,908.73 |
| Taxes Payable |
111,664,831.76 |
| Interest Payable |
-- |
| Dividend Payable |
192,676.00 |
| Other payables |
113,922,228.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
340,434,193.74 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,238,288,744.23 |
| Long-term Loans |
2,968,678,824.00 |
| Bonds Payable |
251,284,762.27 |
| Long-Term Accounts Payable |
1,838,744,492.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,886.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,581,366,488.04 |
| Total Liabilities |
6,819,655,232.27 |
| Paid-In Capital(Or Share Stock) |
2,434,287,059.00 |
| Capital Surplus |
1,405,331,941.68 |
| Surplus Reserve |
226,666,507.84 |
| LESS:Treasury Stock |
105,715,450.00 |
| Undistributed Profits |
1,455,091,148.93 |
| Minority Stockholder's Interest |
25,474,510.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,467,032,323.72 |
| Owner's Equity（Stockholder's Equity） |
5,492,506,833.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,312,162,066.07 |
